Vident Advisory’s Supernus Pharmaceuticals SUPN Stock Holding History

Vident Advisory’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$449K	Sell
2025 Q1	$488K	Buy
2024 Q4	$520K	Buy
2024 Q3	$439K	Sell
2024 Q2	$612K	Buy
2024 Q1	$517K	Buy
2023 Q4	$400K	Buy
2023 Q3	$302K	Buy